Evidence map›Paper›PMID 23869016›Full record

ArticleScience (New York, N.Y.)2013

Loss of function of the melanocortin 2 receptor accessory protein 2 is associated with mammalian obesity.

Masato Asai, Shwetha Ramachandrappa, Maria Joachim, Yuan Shen, Rong Zhang, Nikhil Nuthalapati, Visali Ramanathan, David E Strochlic, Peter Ferket, Kirsten Linhart and 12 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 136 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
136citing papers in PubMed, 3 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

136 citing papers in PubMed, 3 syntheses or guidelines pooled it, 300 citations in OpenAlex.

  1. Association of Mutations in theInternational journal of molecular sciences · 2026
    Pooled it
  2. Pooled it
  3. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline.The Journal of clinical endocrinology and metabolism · 2017 · on this map
    Guideline
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Management of Childhood Obesity.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

76 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Masato AsaiDivision of Endocrinology, Department of Medicine, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.
Shwetha Ramachandrappa
Maria Joachim
Yuan Shen
Rong Zhang
Nikhil Nuthalapati
Visali Ramanathan
David E Strochlic
Peter Ferket
Kirsten Linhart
Caroline Ho
Tatiana V Novoselova
Sumedha Garg
Martin Ridderstråle
Claude Marcus
Joel N Hirschhorn
Julia M Keogh
Stephen O'Rahilly
Li F Chan
Adrian J Clark
I Sadaf Farooqi
Joseph A Majzoub
Harvard University · USBoston Children's Hospital · USNorth Carolina State University · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI POMEROY, SCOTT LOREN · 1985 to 2015
$26.2M
PHD TRAINING IN NEUROSCIENCET32MH020017 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI JOHN ASSAD · 1997 to 2026
$15.8M
Cell Interactions in the Inflamed Intestinal MucosaR01DK075787 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI JOEL N HIRSCHHORN · 2007 to 2026
$13.1M
Research in Development Endocrinology and MetabolismT32DK007699 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI JOEL N HIRSCHHORN · 1992 to 2026
$7.1M
Medical Research Council G0600408Medical Research Council G0600717Medical Research Council G0802796Medical Research Council G0900554Medical Research Council G9824984Medical Research Council MC_UU_12012/5NICHD NIH HHS P30-HD18655NIDDK NIH HHS R01 DK075787NIDDK NIH HHS R01DK075787NIDDK NIH HHS T32 DK007699NIMH NIH HHS T32 MH020017Wellcome Trust 098497
6 · The paper itself

Abstract

Melanocortin receptor accessory proteins (MRAPs) modulate signaling of melanocortin receptors in vitro. To investigate the physiological role of brain-expressed melanocortin 2 receptor accessory protein 2 (MRAP2), we characterized mice with whole-body and brain-specific targeted deletion of Mrap2, both of which develop severe obesity at a young age. Mrap2 interacts directly with melanocortin 4 receptor (Mc4r), a protein previously implicated in mammalian obesity, and it enhances Mc4r-mediated generation of the second messenger cyclic adenosine monophosphate, suggesting that alterations in Mc4r signaling may be one mechanism underlying the association between Mrap2 disruption and obesity. In a study of humans with severe, early-onset obesity, we found four rare, potentially pathogenic genetic variants in MRAP2, suggesting that the gene may also contribute to body weight regulation in humans.

Indexed as

Adaptor Proteins, Signal TransducingAdolescentAnimalsBody Mass IndexBody WeightCarrier ProteinsChildChild, PreschoolEnergy MetabolismFemaleGene DeletionHumansMaleMiceMice, KnockoutObesityAdaptor Proteins, Signal TransducingCarrier ProteinsMC4R protein, mouseMRAP2 protein, humanMRAP2 protein, mouseReceptor Activity-Modifying ProteinsReceptor, Melanocortin, Type 4

Identifiers

PMID23869016
PMCPMC3788688
OpenAlexW2031545914

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.